Key Events This Week
1 June: Stock opens sharply lower at Rs.33.29 (-8.79%) amid broad market weakness
2 June: Formation of Golden Cross signals potential bullish breakout despite price decline
4 June: MarketsMOJO downgrades rating from Strong Sell to Sell citing financial deterioration
5 June: Stock rebounds to Rs.35.10 (+6.01%) on increased volume but closes below week open
1 June 2026: Sharp Opening Decline Amid Market Weakness
Kimia Biosciences Ltd opened the week at Rs.33.29, marking a steep drop of 8.79% from the previous close. This decline was sharper than the Sensex’s 0.96% fall to 35,077.62, reflecting heightened selling pressure on the stock. The volume of 7,762 shares traded was relatively robust for this micro-cap, suggesting active participation in the sell-off. The broad market weakness set a challenging tone for the stock’s performance in the early week.
2 June 2026: Golden Cross Formation Amid Price Decline
Despite the stock price falling further by 1.35% to Rs.32.84, Kimia Biosciences Ltd formed a significant technical pattern known as the Golden Cross on this day. The 50-day moving average crossed above the 200-day moving average, a classic bullish indicator signalling potential long-term upward momentum. However, the immediate price reaction was negative, with the stock underperforming the Sensex, which gained 0.43% to 35,227.64. This divergence highlighted the mixed technical and market sentiment prevailing around the stock.
Our latest monthly pick, this Small Cap from Oil Exploration/Refineries, is showing strong performance since announcement! See why our Investment Committee chose it after screening 50+ candidates.
- - Investment Committee approved
- - 50+ candidates screened
- - Strong post-announcement performance
3 June 2026: Minor Recovery Despite Market Dip
The stock edged up by 0.49% to Rs.33.00 on low volume of 898 shares, while the Sensex declined 0.34% to 35,107.33. This slight recovery suggested some short-term buying interest, possibly influenced by the Golden Cross signal. However, the modest volume and limited price gain indicated cautious investor sentiment amid ongoing uncertainty.
4 June 2026: Downgrade to Sell Amid Financial and Technical Shifts
MarketsMOJO downgraded Kimia Biosciences Ltd’s rating from Strong Sell to Sell on 3 June, reflecting a nuanced shift in the company’s outlook. The downgrade was driven by a sharp deterioration in financial performance, including a 74.9% drop in profit before tax excluding other income to ₹0.75 crore and an 83.6% fall in net profit after tax to ₹0.37 crore for the March 2026 quarter. Net sales contracted by 13.6% to ₹27.20 crore, and earnings per share fell to ₹0.08.
Despite some mild technical improvements such as daily moving averages turning mildly bullish and positive weekly MACD and KST indicators, monthly technicals remained bearish. The company’s high debt-to-equity ratio of 14.13 times and low return on capital employed of 9.76% underscored structural challenges. The stock closed at Rs.33.11, up 0.33%, while the Sensex gained 0.19% to 35,175.61.
Considering Kimia Biosciences Ltd? Wait! SwitchER has found potentially better options in and beyond. Compare this micro-cap with top-rated alternatives now!
- - Better options discovered
- - + beyond scope
- - Top-rated alternatives ready
5 June 2026: Strong Rebound on High Volume
Kimia Biosciences Ltd rebounded sharply by 6.01% to close at Rs.35.10 on increased volume of 9,101 shares, the highest for the week. This recovery came despite the Sensex declining 0.10% to 35,141.95, indicating stock-specific buying interest possibly linked to the earlier Golden Cross formation and the recent rating adjustment. However, the stock still closed below the week’s opening price of Rs.36.50, reflecting ongoing volatility and investor caution.
| Date | Stock Price | Day Change | Sensex | Day Change |
|---|---|---|---|---|
| 2026-06-01 | Rs.33.29 | -8.79% | 35,077.62 | -0.96% |
| 2026-06-02 | Rs.32.84 | -1.35% | 35,227.64 | +0.43% |
| 2026-06-03 | Rs.33.00 | +0.49% | 35,107.33 | -0.34% |
| 2026-06-04 | Rs.33.11 | +0.33% | 35,175.61 | +0.19% |
| 2026-06-05 | Rs.35.10 | +6.01% | 35,141.95 | -0.10% |
Key Takeaways
Positive Signals: The formation of the Golden Cross on 2 June is a notable technical milestone suggesting potential for a bullish breakout and improved momentum. Mildly bullish daily and weekly technical indicators towards the end of the week support this view. The strong rebound on 5 June with increased volume indicates some renewed investor interest.
Cautionary Factors: Despite technical optimism, the stock underperformed the Sensex over the week, falling 3.84% versus the benchmark’s 0.78% decline. The downgrade from Strong Sell to Sell by MarketsMOJO reflects significant financial deterioration, including steep declines in profitability and sales. High leverage and weak long-term growth trends remain structural concerns. Mixed monthly technical indicators and ongoing volatility advise prudence.
Overall, Kimia Biosciences Ltd’s week was characterised by a tension between emerging technical momentum and persistent fundamental challenges. The stock’s micro-cap status and financial weaknesses continue to weigh on sentiment despite some encouraging technical developments.
Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →
